Skip to main content

​Former Sarepta CEO’s accelerator spawns its first biotech

The startup, called Landos Biopharma, is getting $10 million as it seeks to develop treatments for painful autoimmune diseases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.